Morten A. Nielsen

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications

Virus-like particle display of the SARS-CoV-2 receptor-binding domain using a modular tag/catcher system enhances immunogenicity of a DNA vaccine in mice.

Virus-like particle display of the SARS-CoV-2 receptor-binding domain using a modular tag/catcher system enhances immunogenicity of a DNA vaccine in mice.

Journal: Vaccine
Published: April 20, 2026

Field Testing of a Virus-Particle-Based Sow Vaccine Against F4 and STb-Positive Escherichia coli.

Field Testing of a Virus-Particle-Based Sow Vaccine Against F4 and STb-Positive Escherichia coli.

Journal: Vaccines
Published: March 16, 2026

Epitope-selective vaccine designs to elicit protective antibodies against the Plasmodium falciparum circumsporozoite protein.

Epitope-selective vaccine designs to elicit protective antibodies against the Plasmodium falciparum circumsporozoite protein.

Journal: NPJ vaccines
Published: March 04, 2026

A high-throughput assay to measure antibodies that block adhesion of Plasmodium falciparum infected erythrocytes to chondroitin sulfate A.

A high-throughput assay to measure antibodies that block adhesion of Plasmodium falciparum infected erythrocytes to chondroitin sulfate A.

Journal: Journal of immunological methods
Published: June 28, 2025

Outer Membrane Proteins as Vaccine Targets Against Lawsonia intracellularis in Piglets.

Outer Membrane Proteins as Vaccine Targets Against Lawsonia intracellularis in Piglets.

Journal: Vaccines
Published: December 05, 2024

A modular mRNA vaccine platform encoding antigen-presenting capsid virus-like particles enhances the immunogenicity of the malaria antigen Pfs25.

A modular mRNA vaccine platform encoding antigen-presenting capsid virus-like particles enhances the immunogenicity of the malaria antigen Pfs25.

Journal: Nature nanotechnology
Published: January 25, 2024

Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomers.

Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomers.

Journal: NPJ Parkinson's disease
Published: December 19, 2023

Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate.

Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate.

Journal: Nature communications
Published: October 09, 2023

A Virus-like Particle-Based F4 Enterotoxigenic Escherichia coli Vaccine Is Inhibited by Maternally Derived Antibodies in Piglets but Generates Robust Responses in Sows.

A Virus-like Particle-Based F4 Enterotoxigenic Escherichia coli Vaccine Is Inhibited by Maternally Derived Antibodies in Piglets but Generates Robust Responses in Sows.

Journal: Pathogens (Basel, Switzerland)
Published: September 13, 2023

Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines.

Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines.

Journal: iScience
Published: March 27, 2023

A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines.

A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines.

Journal: Vaccines
Published: November 08, 2022

Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA.

Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA.

Journal: Lab animal
Published: September 13, 2022
Showing 1-12 of 58

Last Updated: 09/26/2026